Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Genitourinary 1

Conditions

Esophageal Neoplasms 48Rectal Neoplasms 42Pancreatic Neoplasms 29Esophageal Squamous Cell Carcinoma 20Adenocarcinoma Of Esophagus 15Stomach Neoplasms 14Colorectal Neoplasms 8Anus Neoplasms 8Carcinoma, Hepatocellular 7Neoplasms 6Neoplasm Metastasis 6Cholangiocarcinoma 5Locally Advanced Rectal Cancer 4Uterine Cervical Neoplasms 3Sarcoma 3Melanoma 3Anal Canal Carcinoma 3Adenocarcinoma 3Vulvar Neoplasms 2Vaginal Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Diseases 2Endometrial Neoplasms 2Diabetes Mellitus, Insulin-Dependent, 12 2Colonic Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Gemcitabine 95Cisplatin 72Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 13tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Radiation × Gastrointestinal × Clear all
NCT03482102 2026-05-04

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

Massachusetts General Hospital

Phase 2 Active not recruiting
37 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 13 charts
GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡